Loading…

Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models

Highlights • C6-ceramide nanoliposome and vinblastine combination treatment resulted in blockade of autophagy maturation/degradation. • Combination treatment synergistically enhanced cytotoxicity and apoptotic cell death in vitro. • Combination treatment resulted in synergistic tumor growth suppress...

Full description

Saved in:
Bibliographic Details
Published in:Cancer letters 2013-09, Vol.337 (2), p.254-265
Main Authors: Adiseshaiah, Pavan P, Clogston, Jeffrey D, McLeland, Christopher B, Rodriguez, Jamie, Potter, Timothy M, Neun, Barry W, Skoczen, Sarah L, Shanmugavelandy, Sriram S, Kester, Mark, Stern, Stephan T, McNeil, Scott E
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • C6-ceramide nanoliposome and vinblastine combination treatment resulted in blockade of autophagy maturation/degradation. • Combination treatment synergistically enhanced cytotoxicity and apoptotic cell death in vitro. • Combination treatment resulted in synergistic tumor growth suppression and TUNEL staining, without increasing toxicity. • In summary, data support a synergistic antitumor activity of the combination treatment, mediated by an autophagy mechanism.
ISSN:0304-3835
1872-7980
1872-7980
DOI:10.1016/j.canlet.2013.04.034